ICON9

Trial description
An international phase III randomised study to evaluate the efficacy of maintenance therapy with olaparib and cediranib or olaparib alone in patients with relapsed platinum-sensitive ovarian cancer following a response to platinum-based chemotherapy
Contact name
Dr Joo Ern Ang
Trial start date
Thursday, August 13, 2020
Trial end date
Wednesday, June 30, 2021
Trial tumour type
Gynaecological
Show on Radiotherapy
No